hlorofils pluss (2021.) šķidrums
šķidrums
wellteen® her (2017.) tablete
vitabiotics ltd. - tablete
hlorofils (2020.) šķidrums
alter medica jan szupina - šķidrums
wellteen® him (2017.) tablete
vitabiotics ltd. - tablete
lactoseven® (paziņots 2011.) tablete
vitabalans oy - tablete
lactoseven tablete
vitabalans oy - tablete
frisolac® gold lactose free pulveris
german products baltics, sia - pulveris
frisolac® gold lactose free pulveris
german products baltics, sia - pulveris
frisolac® gold lactose free pulveris
german products baltics, sia 40003980400 silzemnieki 1, garupe, carnikavas nov., lv2163, latvija - pulveris - cits - Īpašiem medicīniskiem nolūkiem paredzēta pārtika
yescarta
kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - antineoplastiski līdzekļi - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.